TT
KYNB

Tiedemann Trust’s Kyntra Bio KYNB Stock Holding History

Tiedemann Trust’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		$358K Hold
874
– – 0.07% 54
2016
Q1 		$465K Hold
874
– – 0.07% 47
2015
Q4 		$665K Hold
874
– – 0.1% 47
2015
Q3 		$479K Hold
874
– – 0.04% 41
2015
Q2 		$513K Buy
+874
New +$508K 0.04% 48

Other funds holding KYNB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Tiedemann Trust's KYNB Position: Q2 2016 in Review

Tiedemann Trust held its Kyntra Bio (KYNB) position steady in Q2 2016 at 874 shares worth $358K. The position accounts for 0.07% of the portfolio, ranked #54.

Tiedemann Trust first reported a position in KYNB in Q2 2015 and has held it in 5 quarters since. The position peaked at $665K in Q4 2015. 146 funds tracked by Wall St. Rank hold KYNB as of Q2 2016.

  • Tiedemann Trust held 874 shares of Kyntra Bio worth $358K as of Q2 2016.
  • Tiedemann Trust left its Kyntra Bio share count unchanged in Q2 2016.
  • Kyntra Bio made up 0.07% of Tiedemann Trust's portfolio in Q2 2016, its #54 holding.
  • Tiedemann Trust first reported a position in Kyntra Bio in Q2 2015 and has held it in 5 quarters since.
  • Tiedemann Trust's Kyntra Bio position peaked at $665K in Q4 2015.
  • 146 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2016.

Based on Tiedemann Trust's 13F filing for Q2 2016, filed 12 Aug 2016.